The global pharmaceutical industry witnessed a 32% rise in compound annual growth rate (CAGR) in new job postings related to robotics since 2020, according to GlobalData's Job Analytics database. New job postings increased by 59% year-on-year in 2021 and by 10% year-on-year in 2022.

Notably, computer and mathematical occupations jobs accounted for 20% share of the global pharmaceutical industry’s robotics-related new job postings since 2020.  

Computer and mathematical occupations, with a share of 20%, emerged as the top robotics-related job roles within the pharmaceutical industry since 2020, with new job postings rising by 100% year-on-year in 2021 and by 10% year-on-year in 2022.

Architecture and engineering occupations came in second with a share of 18%, with new job postings rising by 187% year-on-year in 2021 and falling by 42% year-on-year in 2022.

The other prominent robotics roles include healthcare practitioners and technical occupations with a 15% share, management occupations with a 15% share and life, physical, and social science occupations with a 13% share.  

The top five companies, in terms of the number of new job postings tracked by GlobalData, since 2020 were Johnson & Johnson, Banner Health, Takeda Pharmaceutical, Mercy Health, and Novo Nordisk. Together they accounted for a combined share of 57% of all robotics-related new jobs in the pharmaceutical industry.

Johnson & Johnson posted 2,513 robotics-related jobs since 2020, followed by Banner Health with 645 jobs, and Takeda Pharmaceutical with 633 jobs, according to GlobalData’s Job Analytics database.

New job postings by Johnson & Johnson increased by 136% year-on-year in 2021 and decreased by 9% year-on-year in 2022, while those by Banner Health increased by 83% in 2021 and by 25% in 2022. 

The largest share of robotics-related new job postings in the pharmaceutical industry since 2020 was in the US with 71%, followed by Poland (4%) and Ireland (3%). The share represented by the US decreased by nine percentage points from 74% in 2021 to 65% in 2022.

The global pharmaceutical industry experienced a 22% rise in compound annual growth rate (CAGR) in company filings mentions of robotics since 2020. Key companies in terms of mentions include Apollo Hospitals, Johnson & Johnson, and Aster DM Healthcare, according to GlobalData’s analysis of over 260 pharmaceutical company filings.

Notably, since 2020, robotics was the most referenced theme in terms of mentions, ahead of artificial intelligence, future of work and big data, according to GlobalData's Company Filings database. Mentions related to robotics increased by 1% year-on-year in 2021 and decreased by 16% year-on-year in 2022.

Of the 50 leading companies in the pharmaceutical industry, Fleury had the highest year-on-year increase in references to robotics in 2022. GlobalData identified 4 robotics related sentences in the company's filings in 2022, 3% of all sentences. Meanwhile, Merck had the highest year-on-year increase in references for robotics in 2021. GlobalData identified 9 robotics related sentences in the company's filings in 2021, 7% of all sentences.

GlobalData’s Company Filings Analytics also applies a sentiment weight to reference sentences, based on how positive the sentiment has turned.

Sentiment score is based on the level of positivity on a scale of 0 to 1. The average sentiment score for robotics in 2022 was 0.86, which was more positive compared to the average industry sentiment of 0.44.